Hi SF Community, I am pleased to present an exciting acquisition opportunity which has quickly drawn interest from search funds as well as strategic buyers. It is a licensed online pharmacy that has achieved extraordinary momentum, with monthly revenue growing from £117k to £512k in just six months.

Most of this revenue is recurring, driven by a loyal customer base. A rare chance to acquire or partner with a high-margin business positioned as a leader in its niche within the UK healthcare market.

Key Highlights:

✅ 24% EBITDA Margins – With potential for further optimization. ✅ Profitable Since Month 2 – Financially resilient from the start. ✅ Organic Growth – No reliance on heavy paid advertising. ✅ Recurring Revenue – Loyal customers with high monthly spend. ✅ £7 Million Revenue Forecast for 2025 – Significant growth runway. ✅ Niche Market Focus – Positioned in a high-demand, underserved healthcare niche segment benefiting from market shifts.

Strategic acquirers and financial buyers have already shown strong interest in recent days, with multiple offers expected soon. The owners are exploring a sale or strategic partnership for fair and transparent reasons detailed in the information memorandum.